(1 - 18 from 24
)
Alcami, Solasia Enter API Mfg. Pact - Contract Pharmawww.contractpharma.com › contents › view_breaking-news
www.contractpharma.com
"We are pleased to entrust Alcami with this project," said Mr. Yoshihiro Arai, president and chief executive officer of Solasia Pharma, K.K. ...
Isofol enters licensing agreem - GuruFocus.com
www.gurufocus.com
... Japan," said Yoshihiro Arai, President & CEO of Solasia. Isofol's drug candidate arfolitixorin is being evaluated in the ongoing global Phase
PledPharma och Solasia ingår licensavtal för att utveckla och...
view.news.eu.nasdaq.com
Solasia är väl rustat för att stödja PledPharma under den återstående kliniska utvecklingen och den lokala registreringsprocessen i Japan för att sedan effektivt lansera produkten på de viktiga asiatiska marknaderna”, säger Yoshihiro Arai, President och Chief Executive Officer, Solasia. Som PledPharma ...
PledPharma and Solasia enter license agreement to develop ...www.globenewswire.com › news-release ›
www.globenewswire.com
... in Japan, and to effectively launch the product in key Asian markets,” said Yoshihiro Arai, President and Chief Executive Officer, Solasia.
sorted by relevance / date